- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Chronic Myelogenous Leukemia - Chronic Phase
Total 32571 results
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Immunex CorporationWithdrawnAcute Myelogenous Leukemia | Chronic Myelogenous Leukemia
-
M.D. Anderson Cancer CenterCompletedChronic Myelogenous LeukemiaUnited States
-
Beth Israel Deaconess Medical CenterNational Institutes of Health (NIH); Teva Pharmaceuticals USATerminatedChronic Myelogenous LeukemiaUnited States
-
Novartis PharmaceuticalsCompletedCHRONIC MYELOGENOUS LEUKEMIACanada, Australia, Spain, Argentina, France, Brazil
-
Kerman University of Medical SciencesTerminatedChronic Myelogenous LeukemiaIran, Islamic Republic of
-
Novartis PharmaceuticalsCompletedChronic Myelogenous LeukemiaChina, Argentina, Russian Federation, Germany, Guatemala, Panama, Colombia, Mexico, Brazil, India, Poland, Venezuela
-
University of Massachusetts, WorcesterTerminatedChronic Myelogenous LeukemiaUnited States
-
BayerCompletedChronic Myelogenous LeukemiaUnited States, France
-
M.D. Anderson Cancer CenterCompletedChronic Myelogenous LeukemiaUnited States
-
New Mexico Cancer Care AllianceWithdrawnChronic Myelogenous LeukemiaUnited States
-
Novartis PharmaceuticalsCompletedChronic Myelogenous LeukemiaUnited States
-
Astex Pharmaceuticals, Inc.Eisai Inc.CompletedChronic Myelogenous LeukemiaUnited States, Canada
-
M.D. Anderson Cancer CenterRecruitingChronic Myelogenous LeukemiaUnited States
-
Bristol-Myers SquibbCompletedLeukemia, Lymphoblastic, Acute, Philadelphia-Positive | Myeloid Leukemia, Chronic, Accelerated PhaseAustralia, Canada, France, Germany, Italy, Korea, Republic of, Taiwan, Thailand, United States, Spain, Austria, Denmark, Belgium, Sweden, Switzerland, Netherlands, Peru, South Africa, Philippines, Singapore, Russian Federation, Br... and more
-
American University of Beirut Medical CenterRecruitingChronic Myelogenous LeukemiaLebanon
-
University of Massachusetts, WorcesterBristol-Myers SquibbTerminatedChronic Myelogenous LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Recurrent Hodgkin Lymphoma | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia | Acute Lymphoblastic Leukemia | Lymphoblastic Lymphoma | Myelodysplastic Syndrome | Plasma Cell Myeloma | Aplastic Anemia | Recurrent Non-Hodgkin... and other conditionsUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Completed
-
Novartis PharmaceuticalsActive, not recruitingChronic Myelogenous LeukemiaBelgium, Spain, Austria, Germany, Italy, France, Netherlands, Sweden, Japan, United States, Greece, United Kingdom, Bulgaria, Hungary, Argentina, Poland, Colombia, Ireland, Denmark
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Acute Myeloid Leukemia | Refractory Hodgkin Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Acute Lymphoblastic Leukemia | Myelodysplastic Syndrome | Chronic Phase Chronic Myelogenous Leukemia | Recurrent Small Lymphocytic Lymphoma | Chronic Myelogenous Leukemia | Refractory Chronic Lymphocytic Leukemia and other conditionsUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedChronic Myelomonocytic Leukemia | Chronic Myelogenous LeukemiaUnited States
-
Lindsay Rein, MDKiadis PharmaNot yet recruitingCML (Chronic Myelogenous Leukemia
-
Hoffmann-La RocheCompletedMyelogenous Leukemia, ChronicGermany
-
Shenzhen TargetRx, Inc.M.D. Anderson Cancer CenterRecruitingChronic Myelogenous LeukemiaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)CompletedChronic Myelogenous LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedLeukemia | Chronic Myelogenous LeukemiaUnited States
-
M.D. Anderson Cancer CenterWithdrawn
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Previously Treated Myelodysplastic Syndrome | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive and other conditionsUnited States
-
Shenzhen TargetRx, Inc.Peking University People's HospitalRecruitingChronic Myelogenous LeukemiaChina
-
Novartis PharmaceuticalsActive, not recruitingChronic Myelogenous LeukemiaUnited States, United Kingdom, Hungary, Japan, Saudi Arabia, Australia, Germany, Canada, France, Netherlands, Spain, Lebanon, Turkey, Korea, Republic of, Argentina, Brazil, Bulgaria, Czechia, Israel, Italy, Mexico, Romania, Russian... and more
-
Bristol-Myers SquibbCompletedChronic Myeloid Leukemia | Philadelphia Chromosome | Chronic Myeloid Leukemia in Chronic PhaseChina
-
Novartis PharmaceuticalsCompletedChronic Myelogenous LeukemiaUnited States, Canada
-
Novartis PharmaceuticalsCompleted
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.UnknownChronic Myelogenous LeukemiaChina
-
S*BIOCompletedMyelodysplastic Syndromes | Myelofibrosis | Chronic Myelomonocytic Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous LeukemiaUnited States
-
Masaryk UniversityActive, not recruitingChronic Myeloid Leukemia, Chronic Phase | Withdrawal;DrugCzechia
-
Novartis PharmaceuticalsNot yet recruitingPhiladelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase
-
Hackensack Meridian HealthTerminatedMyeloproliferative Disorders | Myelodysplastic Syndrome | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Myeloid MalignanciesUnited States
-
National Cancer Institute (NCI)TerminatedAcute Myeloid Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1... and other conditionsUnited States
-
Novartis PharmaceuticalsActive, not recruitingChronic Myelogenous LeukemiaSpain, United Kingdom, Germany, Canada, Austria, France, Korea, Republic of, Greece, Singapore, Italy, Argentina, Poland, Vietnam, Malaysia, Oman, Brazil
-
Junmin LiSuspendedChronic Myelogenous LeukemiaChina
-
Versailles HospitalUniversity Hospital, Bordeaux; Maisonneuve-Rosemont HospitalCompletedChronic Myelogenous Leukemia, BCR/ABL PositiveFrance, Canada
-
M.D. Anderson Cancer CenterAbiogen PharmaTerminatedChronic Myelogenous LeukemiaUnited States
-
John MascarenhasNational Cancer Institute (NCI); National Institutes of Health (NIH); Celgene... and other collaboratorsCompletedIDH2 Mutation | Accelerated/Blast-phase Myeloproliferative Neoplasm | Chronic-phase MyelofibrosisUnited States, Canada
-
National Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Promyelocytic Leukemia (M3) | Previously Treated Myelodysplastic Syndromes | Recurrent Adult Acute Lymphoblastic Leukemia | Relapsing Chronic Myelogenous Leukemia | Refractory Anemia With Excess Blasts | Blastic Phase Chronic Myelogenous Leukemia and other conditionsUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) | Secondary Acute Myeloid Leukemia and other conditionsUnited States
-
Novartis PharmaceuticalsActive, not recruitingHematologic Diseases | Chronic Myelogenous Leukemia | CML | Leukemia, Myeloid ChronicTaiwan, Italy, Spain, United Kingdom, Germany, United States, Korea, Republic of, France, Russian Federation, Canada, Denmark, Poland, Portugal, Austria, Czechia
-
Centre Hospitalier Universitaire de BesanconCompletedChronic Myeloid LeukemiaFrance
-
M.D. Anderson Cancer CenterNovartisCompletedLeukemia, Myeloid, ChronicUnited States